NexPoint Residential Trust, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NexPoint Residential Trust, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $251.28M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $259.70M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $277.53M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $263.95M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $219.24M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $50.55M | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $50.99M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | $50.68M | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $52.58M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | $49.68M | Feb 22, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($32.03M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.11M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $44.26M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($9.26M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $23.04M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($4.20M) | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | $29.55M | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | ($9.29M) | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | $27.96M | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | ($13.27M) | Feb 22, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.93M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $83.56M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $113.18M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $46.25M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $64.42M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $82.72M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $142.59M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $30.53M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $91.65M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $21.85M | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.59M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $73.57M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $96.58M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $79.10M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $73.27M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $57.23M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $51.37M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $41.74M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $37.51M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $33.78M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.89B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.91B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.11B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $2.23B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $2.06B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.83B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.87B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $1.16B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $1.06B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.04B | Feb 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.49B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.61B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.70B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.59B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.42B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.44B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $862.62M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $813.80M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $779.30M | Feb 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $410.37M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $494.62M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $519.67M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $469.85M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $407.93M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $426.24M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $296.03M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $239.44M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $231.54M | Feb 15, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($123.41M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($38.03M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $11.49M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $11.88M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $59.21M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $75.32M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $63.78M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | ($6.76M) | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $19.29M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($14.58M) | Feb 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.70M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $23.15M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $12.37M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $16.76M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $49.45M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $24.46M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $25.67M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $19.86M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $16.04M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $22.71M | Feb 15, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $1.58B | Feb 27, 2024 |
| FY2022 | Dec 31, 2022 | $1.68B | Feb 24, 2023 |
| FY2021 | Dec 31, 2021 | $1.56B | Feb 18, 2022 |
| FY2020 | Dec 31, 2020 | $1.35B | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | $1.41B | Feb 21, 2020 |
| FY2018 | Dec 31, 2018 | $845.71M | Feb 19, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 22, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 22, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 22, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 22, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25.36M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 25.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 25.67M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 25.55M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 25.50M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 25.02M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 25.25M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 23.50M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 21.05M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 21.04M | Feb 15, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.53M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $49.30M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $44.80M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $40.64M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $35.80M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $32.30M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $28.05M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $22.27M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $19.26M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $17.78M | Feb 19, 2019 |